Nitric oxide: Experimental Analysis of its Role in Brain Tissue in Simulated Ischemia
A joint study conducted by scientists at the National Academy of Sciences in Belarus and Kazan Federal University in Russia, looks at the role of nitric oxide (NO) in brain tissue in simulated ischemia in rats.
In 1988, Robert F. Furchgott, Louis J. Ignarro and Ferid Murad received a Nobel Prize for their discoveries concerning nitric oxide (NO) as a signaling molecule in cardiovascular, reproductive, nervous and other systems. At that time, the discovery brought hope to many patients with hypoxia, especially the ones suffering from impotence.
But despite the good news, NO appeared to have other functional properties. Gas NO molecule sometimes acted cunningly causing side effects instead of correction of disordered functions. Since then, this "two-facedness" of NO triggered activity of scientists who wanted to understand the complex mechanisms of its action.
In this new study, the team of scientists conducted experimental analysis of NO role in brain tissue in simulated ischemia in rats.
The authors of the study apply complex methods for NO identification, including electron paramagnetic resonance (EPR) aiming at recording NO content in hippocampal tissue of intact rats and the ones after simulation of ischemic and hemorrhagic stroke.
Direct NO measurements using EPR spectroscopy showed that NO formation in hippocampal area decreases up to 2-3 times in 5 hours after appearance of both ischemic and hemorrhagic strokes' signs, and this decrease lasts for 24 and 72 hours.
Results demonstrate that systemic character of NO production lowering during simulation of ischemic events in brain reflects the consequences of central dysregulation of whole organism's functions. This should be taken into account during further studies on correction of vital functions in patients with stroke.
Finally, analysis of literature and results of conducted experiments demonstrated that comprehensive approach and application of precision methods of NO level measurement in brain tissue contributed to real data acquisition on the complex dynamics of NO production in nerve tissue in health and disease.
"The development of brain ischemia is often commonly referred to not only by physicians, but also other "specialists" as James Bond." according to Vladimir Kulchitsky, National Academy of Sciences, Belarus.
"My reference points to an episode from the famous fiction movie where substance with "NO" abbreviation was developed." clarifies the author to further explain this association. "James Bond overcame long underground corridors filled with water with no signs of hypoxia and ended up in hall with female figure throwing a 'Yes'-shaped shadow. He wound his arms around it to immobilize the possible opponent and asked: 'Why 'Yes'? I expected traditional 'No' from a woman'. A loudspeaker replied: 'Stop strangling the young scientist! He is co-author of the article shedding light on ambiguous NO substance'.
This article has been republished from materials provided by Pensoft Publishers. Note: material may have been edited for length and content. For further information, please contact the cited source. The original story is licensed under a Creative Commons License.
Gainutdinov K, Pashkevich S, Andrianov V, Yafarova G, Dosina M, Bogodvid T, Stukach J, Silant'eva D, Zamaro A, Sushko T, Kulchitsky V (2017) Participation of NO-synthase in Control of Nitric Oxide Level in Rat Hippocampus after Modelling of Ischaemic and Haemorrhagic Insult. BioDiscovery 20: e14810. https://doi.org/10.3897/biodiscovery.20.e14810.
Using Epigenetic Signatures and Machine Learning to Improve DiagnosisNews
Unique epigenetic signatures for nine neurodevelopmental disorders have been identified, lending to a better method of diagnosis for disorders with much clinical overlap.READ MORE
Valence Mapped: Brain study reveals roots of desire and dislike in the amygdalaNews
Researchers map the amygdala's distinct but diverse and dynamic neighbourhoods where feelings are assigned.READ MORE
Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor TreatmentNews
A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.READ MORE